Echo Street Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Other funds holding HZNP
N
PC
ACA
Echo Street Capital Management's HZNP Position: Q3 2022 in Review
Echo Street Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2022, closing a stake of 11,529 shares — an estimated $920K sold.
Echo Street Capital Management first reported a position in HZNP in Q2 2020 and held it in 6 quarters. The position peaked at $1.22M in Q1 2022. 530 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.
- Echo Street Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2022 after selling out during the quarter.
- Echo Street Capital Management sold 11,529 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022, an estimated $920K.
- Echo Street Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2020 and held it in 6 quarters.
- Echo Street Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.22M in Q1 2022.
- 530 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.
Based on Echo Street Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.